ONCO DIAGNOSTICS

Leveraging next-generation sequencing, biomarker profiling, and multi-omics platforms, we deliver high-sensitivity, high-specificity cancer diagnostics to support precision medicine and translational research.

Three tests under ONCO DIAGNOSTICS

1. Onco Precision Dx

Redefining Precision Diagnostics.

Onco Precision Dx is a cutting-edge diagnostic platform that provides comprehensive tumor profiling—including whole-genome sequencing, RNA sequencing, and proteomics—to identify actionable mutations, gene fusions, and biomarkers, empowering oncologists with precise data for confident, personalized treatment decisions across even the most complex cancers.

2. Pathway Explorer

Decoding Tumor Behavior at the Molecular Level

Pathway Explorer is an innovative diagnostic solution that maps disrupted signaling pathways—such as KRAS, TP53, PI3K—to provide oncologists with deep insights into tumor biology, aiding in the understanding of tumor behavior and revealing potential targets for precision therapies.

3. TumorMap pro

A New Dimension of Tumor Analysis

TumorMap Pro is a next-generation diagnostic service that integrates genomic, transcriptomic, proteomic, spatial transcriptomics, and imaging data to deliver a comprehensive view of tumor heterogeneity, enabling precise staging and personalized treatment planning based on the unique molecular and spatial characteristics of each patient’s cancer.